Eman Mohamed Ismail Fayad | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Eman Mohamed Ismail Fayad | Pharmaceutical Science | Best Researcher Award

Assistant Professorr at Taif University, Egypt.

Dr. Eman Mohamed Ismail Fayad, an Assistant Professor at the Department of Biotechnology, Faculty of Science, Taif University, is a committed academic with a dynamic career in biotechnology and zoology. Born in Dakahliah, Egypt, she has built a distinguished career through both teaching and research. Her professional journey spans Egypt and Saudi Arabia, bringing a unique blend of local and international experience to her work. With over a decade at Taif University, Dr. Fayad is well-regarded for her expertise in biotechnology, a field that bridges biological sciences with technological advancements. Her dedication to education, research, and scientific community engagement is further highlighted by her active membership in professional societies, like the El Alamein Union in Egypt. Dr. Fayad’s accomplishments and commitment to the scientific community underscore her eligibility for awards that celebrate research excellence.

Professional Profile

Education

Dr. Fayad’s educational foundation in the biological sciences has been pivotal to her success in academia and research. With an early focus on zoology, she began her academic journey at Mansoura University in Egypt, where she completed her undergraduate and advanced studies. She has cultivated an in-depth understanding of biological sciences, ultimately specializing in biotechnology, a field that allows her to leverage her strong zoological background with technological applications. Her academic training at Mansoura University, a leading institution in Egypt, has equipped her with both theoretical and practical insights necessary for her role as an Assistant Professor. This strong educational background provides a robust base for her teaching and research activities, supporting her contributions to biotechnology and her role in shaping future scientists.

Professional Experience

Dr. Fayad’s experience spans teaching and research roles in both Egypt and Saudi Arabia, positioning her as a versatile academic with international exposure. She began her career in 2007 at Mansoura University, where she taught zoology in the Faculty of Science. In 2011, Dr. Fayad joined the Faculty of Science at Taif University in Saudi Arabia as an Assistant Professor in the Biotechnology Department. This move broadened her academic experience and allowed her to engage with diverse student bodies and academic networks. Her over ten years at Taif University underscore her commitment to teaching and academic research, where she continuously fosters a learning environment that integrates biotechnology advancements with biological sciences.

Research Interest

Dr. Fayad’s research interests focus primarily on biotechnology and its applications in biological sciences, particularly in zoology. This interdisciplinary approach enables her to contribute to projects that require both technological innovation and a deep understanding of biological systems. Her work often involves exploring biotechnological solutions to biological and ecological challenges, a focus that aligns with current scientific priorities for sustainable solutions. Her interest in these areas reflects her commitment to advancing scientific knowledge while addressing real-world challenges through research. Dr. Fayad is keen on using biotechnology to solve complex biological problems, making her research both relevant and impactful in today’s science landscape.

Award and Honor

Throughout her career, Dr. Fayad has received recognition for her contributions to academia and the scientific community. While specific awards were not listed, her longstanding role as an Assistant Professor at Taif University and her membership in professional societies highlight the acknowledgment she has earned from academic institutions and peers. Dr. Fayad’s active engagement in the scientific community, particularly through the El Alamein Union in Egypt, speaks to her reputation and contributions in the field. Her professional accolades not only demonstrate her dedication to her research but also reinforce her commitment to academic excellence and innovation in biotechnology and zoology. These honors position her as a distinguished figure within her field, with a promising trajectory for further achievements.

Conclusion

Dr. Fayad’s academic background, international teaching experience, and interdisciplinary knowledge make her a strong candidate for the Best Researcher Award, particularly if she has contributed to impactful research in biotechnology or zoology. Enhancing her profile with a list of recent publications and additional professional memberships could further solidify her standing among competitors.

Publications top noted

Title: Modelling the COVID‐19 Mortality Rate with a New Versatile Modification of the Log‐Logistic Distribution
Authors: AH Muse, AH Tolba, E Fayad, OA Abu Ali, M Nagy, M Yusuf
Year: 2021
Citations: 48

Title: Proteome based approach defines candidates for designing a multitope vaccine against the Nipah virus
Authors: MA Soltan, MA Eldeen, N Elbassiouny, I Mohamed, DA El-Damasy, E Fayad
Year: 2021
Citations: 38

Title: Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS
Authors: MY Zakaria, E Fayad, F Althobaiti, I Zaki, AH Abu Almaaty
Year: 2021
Citations: 30

Title: Anti-proliferative and immunomodulatory potencies of cinnamon oil on Ehrlich ascites carcinoma bearing mice
Authors: Dalia S. Morsi, Sobhy Hassab El‑Nabi, Mona A. Elmaghraby, Ola A. Hassan, E Fayad
Year: 2022
Citations: 28

Title: Recognition of mRNA N4 acetylcytidine (ac4C) by using non-deep vs. Deep learning
Authors: MS Iqbal, R Abbasi, MB Bin Heyat, F Akhtar, AS Abdelgeliel, S Albogami, E Fayad
Year: 2022
Citations: 27

Title: In Silico Designing of a Multitope Vaccine against Rhizopus microsporus with Potential Activity against Other Mucormycosis Causing Fungi
Authors: MA Soltan, MA Eldeen, N Elbassiouny, HL Kamel, KM Abdelraheem, E Fayad
Year: 2021
Citations: 27

Title: Gamma irradiation assisted the sol–gel method for silver modified-nickel molybdate nanoparticles synthesis: Unveiling the antimicrobial, and antibiofilm activities against some pathogens
Authors: MIA Abdel Maksoud, GS El-Sayyad, E Fayad, A Alyamani, OA Abu Ali
Year: 2021
Citations: 27

Title: Antibacterial, antifungal and antibiofilm activities of silver nanoparticles supported by crude bioactive metabolites of bionanofactories isolated from Lake Mariout
Authors: M Eltarahony, A Ibrahim, H El-Shall, E Ibrahim, F Althobaiti, E Fayad
Year: 2021
Citations: 25

Title: Design and synthesis of newly synthesized acrylamide derivatives as potential chemotherapeutic agents against MCF-7 breast cancer cell line lodged on PEGylated bilosomal nano
Authors: I Zaki, RAI Abou-Elkhair, AH Abu Almaaty, O A. Abu Ali, E Fayad
Year: 2021
Citations: 21

Title: Comparative study between curcumin and nanocurcumin loaded PLGA on colon carcinogenesis induced mice
Authors: FE Elbassiouni, WM El-Kholy, ESM Elhabibi, S Albogami, E Fayad
Year: 2022
Citations: 20

Wirginia Krzyściak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Posted on by ScienceFather

Dr. Wirginia Krzyściak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Acting Head of Department of Medical Diagnostics at the Faculty of Pharmacy of the Medical College of the Jagiellonian University in Krakow, Poland 

Dr. Wirginia Krzyściak is a distinguished researcher and academic leader in the field of medical diagnostics, currently serving as the Acting Head of the Department of Medical Diagnostics at the Jagiellonian University Medical College (JU MC) in Poland. With a career spanning over a decade, she has made significant contributions to the study of schizophrenia, clinical biochemistry, and the relationship between oral microbiota and brain function 🧠. A prolific author with 85 original scientific papers and a strong h-index of 16, Dr. Krzyściak’s work is highly regarded in both national and international academic circles 🌍. She also serves on the editorial boards of several high-impact scientific journals, focusing on biostatistics, brain diseases, and biomolecules related to biofilm diseases. Beyond her research, she is actively involved in mentoring, having supervised numerous master’s and doctoral theses 🎓.

Professional profile

Education📚

Dr. Wirginia Krzyściak has a rich academic background rooted in the medical and pharmaceutical sciences. She earned her Doctoral Degree in Medical Sciences, specializing in clinical biochemistry from Jagiellonian University Medical College (JU MC) in 2009 🎓. In 2018, she achieved her habilitation in Pharmaceutical Science, a prestigious qualification marking her academic excellence and expertise. Dr. Krzyściak’s education has laid a strong foundation for her research endeavors in schizophrenia and clinical diagnostics. She has also contributed to academic literature, authoring numerous papers and chapters in textbooks 📚. Her academic qualifications are further bolstered by her active membership in several scientific societies, including the Polish Microbiology Society and the Polish Biochemistry Society. Through her education, Dr. Krzyściak has gained deep insights into the biochemical and molecular aspects of schizophrenia, positioning her as a leading researcher in her field 🔬.

Professional Experience🏛️

Dr. Wirginia Krzyściak has over a decade of professional experience in the fields of medical diagnostics and clinical biochemistry. Since 2010, she has held various academic positions at Jagiellonian University Medical College (JU MC), starting as an Assistant and later becoming an Adjunct in the Department of Medical Diagnostics 🧑‍🔬. She is currently the Acting Head of the Department, where she leads cutting-edge research on schizophrenia and biomolecular diagnostics. Beyond her academic role, Dr. Krzyściak is an expert consultant for the Central Medical Laboratory in Bytom 🏥. Her leadership extends to numerous research projects, including those focused on oral microbiota and brain function. Dr. Krzyściak is also deeply involved in mentoring, having supervised 25 master’s theses and two doctoral dissertations 🎓. Her comprehensive experience in research, diagnostics, and teaching makes her a key figure in the field of clinical biochemistry and pharmaceutical sciences.

Research Interest🌐

Dr. Wirginia Krzyściak’s research interests are centered on the intersection of clinical biochemistry, medical diagnostics, and neuroscience 🧠. She has made significant contributions to understanding the biochemical and molecular underpinnings of schizophrenia, focusing on the relationship between oral microbiota and brain function, oxidative stress, and metabolic imbalances 🧪. Her recent projects explore innovative diagnostic biomarkers, particularly in brain diseases and biofilm-related infections, which hold promise for personalized medical approaches. Additionally, Dr. Krzyściak is intrigued by the role of acid stress in central nervous system disorders and the potential therapeutic interventions targeting these pathways. As the principal investigator in multiple national and international research projects, she continues to explore the frontiers of medical diagnostics, aiming to improve individualized patient care through cutting-edge biostatistical and biochemical methodologies 🔬. Her research portfolio reflects a multidisciplinary approach, integrating pharmaceutical sciences with clinical applications for psychiatric conditions like schizophrenia.

Awards and Honors🏆

Dr. Wirginia Krzyściak has received numerous prestigious awards and honors throughout her career 🌟. In 2024, she was awarded the Rector’s Award for Scientific Achievements, recognizing her outstanding contributions to the field of medical diagnostics. The previous year, she received the Bronze Medal for Long Service, acknowledging her decade-long dedication to academia 🏅. She has also been recognized multiple times by the Faculty of Pharmacy at Jagiellonian University Medical College, receiving the Dean’s Award for Scientific Achievements in 2022. Earlier in her career, she earned the Badge of the Krakow branch of the Polish Society of Microbiologists in 2017. Dr. Krzyściak’s accomplishments are a testament to her dedication to scientific research, mentorship, and academic leadership. Her continuous commitment to advancing medical diagnostics, especially in schizophrenia research, has earned her a strong reputation in the scientific community 🧬.

Conclusion:

Dr. Wirginia Krzyściak is an outstanding candidate for the Women Researcher Award. Her extensive experience, significant contributions to schizophrenia research, and leadership roles within academia make her a strong contender. She has demonstrated scientific excellence, international collaboration, and research leadership. However, focusing more on initiatives supporting women in science and engaging more broadly with the public could enhance her profile for this specific award.

Publications top noted📜
  • From Periphery Immunity to Central Domain Through Clinical Interview as a New Insight on Schizophrenia
    Krzyściak, W., Szwajca, M., Śmierciak, N., Skalniak, A., Popiela, T.
    Scientific Reports (2024), 14(1), 5755
    🔬 Citations: 1
  • Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia
    Krzyściak, W., Bystrowska, B., Karcz, P., Popiela, T., Pilecki, M.
    International Journal of Molecular Sciences (2024), 25(4), 2294
    🧠 Citations: 0
  • Modified Lactoperoxidase System as a Promising Anticaries Agent: In Vitro Studies on Streptococcus mutans Biofilms
    Magacz, M., Alatorre-Santamaría, S., Kędziora, K., Pamuła, E., Krzyściak, W.
    International Journal of Molecular Sciences (2023), 24(15), 12136
    🦷 Citations: 1
  • Benefits and Meaning of Lipids Profile in Relation to Oxidative Balance and Brain Morphology in Schizophrenia
    Śmierciak, N., Krzyściak, W., Szwajca, M., Aleksandrovych, V., Pilecki, M.
    International Journal of Molecular Sciences (2023), 24(14), 11375
    🧬 Citations: 3
  • The Association of the Oral Microbiota with the Effects of Acid Stress Induced by an Increase of Brain Lactate in Schizophrenia Patients
    Krzyściak, W., Karcz, P., Bystrowska, B., Popiela, T.J., Pilecki, M.
    Biomedicines (2023), 11(2), 240
    🧫 Citations: 4
  • Safety Assessment of the Modified Lactoperoxidase System—In Vitro Studies on Human Gingival Fibroblasts
    Magacz, M., Papież, M., Kościelniak, D., Pamuła, E., Krzyściak, W.
    International Journal of Molecular Sciences (2023), 24(3), 2640
    🧪 Citations: 2
  • Risk Factors for Weight Gain in Patients with First-Episode Psychosis
    Batko, B., Szwajca, M., Śmierciak, N., Turek, A., Pilecki, M.
    Psychiatria Polska (2023), 57(1), pp. 51–64
    🏋️ Citations: 1
  • Immunological Routine Laboratory Parameters at Admission Influence the Improvement of Positive Symptoms in Schizophrenia Patients After Pharmacological Treatment
    Skalniak, A., Krzyściak, W., Śmierciak, N., Kozicz, T., Pilecki, M.
    Frontiers in Psychiatry (2023), 14, 1082135
    💊 Citations: 4
  • Effect of a Short-Term Intervention with Lactobacillus salivarius Probiotic on Early Childhood Caries—An Open Label Randomized Controlled Trial
    Staszczyk, M., Jamka-Kasprzyk, M., Kościelniak, D., Krzyściak, W., Jurczak, A.
    International Journal of Environmental Research and Public Health (2022), 19(19), 12447
    👶 Citations: 11

Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Dr. Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor at Chosun University, South Korea

Dr. Kyu Min Kim, born on July 13, 1984, is an Associate Professor at the Laboratory of Translational Genetics, Department of Biomedical Science, College of Natural Science, Chosun University, Korea. He also holds a position as a registered pharmacist in the Republic of Korea. 📅🏫

Professional profile

Education📚

Dr. Kim completed his Ph.D. in Pharmacy with a focus on Molecular Pharmacology at Seoul National University (2011-2018), where he investigated antifibrotic targets in hepatic stellate cells. He obtained his M.S. in Pharmacy from Chosun University (2007-2009) and his B.S. in Pharmacy from the same institution (2003-2007). 🎓📚

Professional Experience🏛️

Dr. Kim has extensive experience in academia and research. He served as a Teaching and Research staff at Chosun University (Mar 2018 – Feb 2021) and as a researcher at several institutes, including the Research Institute of Pharmaceutical Science at Chosun University and Seoul National University. His career also includes experience as a pharmacist at Chonnam National University Hospital. 🏥🔬

Research Interest🌐

His research interests span molecular pharmacology, liver pathophysiology, and antifibrotic mechanisms. Dr. Kim focuses on hepatic stellate cell activation, liver fibrosis, and cellular responses to oxidative stress, aiming to understand and address complex biological and therapeutic challenges. 🔬💉

Awards and Honors🏆

Dr. Kim has received several accolades for his work, including the Excellent Paper Award at the 2nd China Chemical Looping Conference (2023), recognition as an Outstanding Graduate Student in Shanghai (2022), and the National Scholarship of the People’s Republic of China (2021). These honors underscore his significant contributions to his field. 🏆🎖️

Achievements🏅
  • Innovative Research Contributions:
    • Developed novel insights into hepatic stellate cell activation and antifibrotic targets, enhancing understanding of liver fibrosis mechanisms. 🔬🧬
    • Investigated the role of sphingosine kinase in liver pathophysiology, providing a deeper comprehension of liver-related diseases. 🌟🧪
  • Academic and Research Excellence:
    • Awarded the Excellent Paper of the 2nd China Chemical Looping Conference (2023). 🏅🔬
    • Recognized as an Outstanding Graduate Student in Shanghai (2022). 🏆🎓
    • Received the National Scholarship of the People’s Republic of China (2021). 🎖️🌍
  • Professional Impact:
    • Significant contributions to molecular pharmacology through various research roles at Chosun University and Seoul National University. 💼🏥
    • Actively involved in advancing pharmacological research and education in his field. 📈👨‍🏫
Publications top noted📜
  • Parkin-Mediated Mitophagy by TGF-β Is Connected with Hepatic Stellate Cell Activation
    • Authors: Lee, J.H., Kim, K.M.*, Jung, E.H., Cho, S.S., Ki, S.H.
    • Journal: International Journal of Molecular Sciences
    • Year: 2023
    • Citations: 2 📄🔬
  • Integrative Roles of Sphingosine Kinase in Liver Pathophysiology
    • Authors: Kim, K.M.*, Shin, E.J., Yang, J.H., Ki, S.H.
    • Journal: Toxicological Research
    • Year: 2023
    • Citations: 4 🧬🔍
  • Identification of Histone Lysine Acetoacetylation as a Dynamic Post-Translational Modification Regulated by HBO1
    • Authors: Gao, Y., Sheng, X., Tan, D., Zhao, Y., Lee, S., Kim, K.M
    • Journal: Advanced Science
    • Year: 2023
    • Citations: 2 📚✨
  • Protective Effect of Castanopsis sieboldii Extract against UVB-Induced Photodamage in Keratinocytes
    • Authors: Lee, H.R., Yang, J.H., Lee, J.H., Kim, K.M., Shin, H.-J., Ki, S.H.
    • Journal: Molecules
    • Year: 2023
    • Citations: 3 🌿🛡️
  • Ferroptosis Contributes to Hepatic Stellate Cell Activation and Liver Fibrogenesis
    • Authors: Cho, S.S., Yang, J.H., Lee, J.H., Kim, K.M*, Ki, S.H.
    • Journal: Free Radical Biology and Medicine
    • Year: 2022
    • Citations: 15 🩸⚠️
  • Regulated in Development and DNA Damage Response 1 Protects Hepatocytes Against Palmitate-Induced Lipotoxicity
    • Authors: Kim, J.H., Kim, K.M*, Yang, J.H., Lee, J.H., Ki, S.H.
    • Journal: Biotechnology and Bioprocess Engineering
    • Year: 2022
    • Citations: 0 🛡️🔬
  • Characterization of Hyperglycemia Due to Sub-Chronic Administration of Red Ginseng Extract via Comparative Global Proteomic Analysis
    • Authors: Na, A.-Y., Jo, J.J., Kwon, O.K., Kim, J.H., Kim, K.M, Ki, S.H., Lee, S.
    • Journal: Scientific Reports
    • Year: 2021
    • Citations: 3 🌱🔬
  • REDD1 Attenuates Hepatic Stellate Cell Activation and Liver Fibrosis via Inhibiting the TGF-β/Smad Signaling Pathway
    • Authors: Cho, S.S., Lee, J.H., Kim, K.M*, Yang, J.H., Ki, S.H.
    • Journal: Free Radical Biology and Medicine
    • Year: 2021
    • Citations: 21 🌟💡
  • Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance
    • Authors: Park, M., Kim, J.W., Kim, K.M*, Cho, Y., Lee, H., Baek, M.C., et al.
    • Journal: Cancer Research
    • Year: 2021
    • Citations: 13 🦠🚀
  • Transforming Growth Factor Beta-Induced FoxO3a Acts as a Profibrotic Mediator in Hepatic Stellate Cells
    • Authors: Kim, S.J., Kim, K.M*, Yang, J.H., Park, E.Y., Ki, S.H.
    • Journal: Toxicological Sciences
    • Year: 2021
    • Citations: 4 🔬🔄

Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Prof. Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor of Beijing Institute of Technology, China

Prof. Shaobo Ruan 🌟 is a distinguished academic with a focus on Pharmaceutics and Bioengineering. He earned his Ph.D. and M.D. in Pharmaceutics from the West China School of Pharmacy, Sichuan University 🎓, where he was mentored by Professors Huile Gao and Qin He. He also holds a B.S. in Pharmaceutics from Wannan Medical College. Prof. Ruan’s career includes significant roles as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science 🏛️, Beijing Institute of Technology, and as a Postdoctoral Associate at the University of Florida and the University of Kansas 🔬. His research and academic pursuits have made notable contributions to the field of Pharmaceutics and Bioengineering, emphasizing interdisciplinary approaches and advanced scientific inquiry.

Professional profile

Education📚

Prof. Shaobo Ruan 🎓 has an impressive educational background in Pharmaceutics. He completed his Ph.D. in Pharmaceutics at West China School of Pharmacy, Sichuan University (2015-2018) 🏫, under the guidance of Professors Huile Gao and Qin He. Prior to that, he earned his M.D. in Pharmaceutics from the same institution (2012-2015) 🏥. His foundational studies were completed with a B.S. in Pharmaceutics from Wannan Medical College (2008-2012) 🎓.

Professional Experience🏛️

Prof. Shaobo Ruan 🌟 has built a notable career in the field of Pharmaceutics and Bioengineering. He is currently serving as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology 🏛️ since September 2021. Previously, he was a Postdoctoral Associate in Pharmaceutics at the University of Florida 🎓 from July 2020 to July 2021. He also held a Postdoctoral Associate position in Bioengineering at the University of Kansas 🔬 from July 2018 to June 2021. His roles have significantly contributed to advancements in his field, integrating research and interdisciplinary approaches.

Research Interest🌐

Prof. Shaobo Ruan 🔬 is deeply engaged in research that bridges Pharmaceutics and Bioengineering. His interests focus on the development and optimization of pharmaceutical formulations, drug delivery systems, and bioengineering applications 🌟. Prof. Ruan explores innovative methods to enhance drug efficacy and safety, integrating advanced technologies and interdisciplinary approaches to address complex challenges in the field. His work aims to advance therapeutic solutions and improve patient outcomes, making significant contributions to both scientific research and practical applications in Pharmaceutics and Bioengineering.

Awards and Honors🏆

Prof. Shaobo Ruan 🌟 has received notable recognition for his contributions to Pharmaceutics and Bioengineering. His excellence in research and academic achievements have earned him prestigious awards and honors 🏅. These accolades reflect his significant impact on the field, highlighting his dedication to advancing pharmaceutical sciences and bioengineering innovations. Prof. Ruan’s commitment to research and education continues to be acknowledged through various awards, underscoring his role as a leading figure in his discipline. 🏆✨

Achievements🏅
  • Ph.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University 🎓
  • M.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University 🏥
  • B.S. in Pharmaceutics from Wannan Medical College 🎓
  • Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology 🏛️
  • Postdoctoral Associate at the University of Florida and University of Kansas 🔬
  • Advanced pharmaceutical formulations and drug delivery systems 🌟
  • Notable contributions to Bioengineering and interdisciplinary research ✨
  • Recognition through prestigious awards and honors 🏆
Projects🛠️
  • Development of Advanced Drug Delivery Systems 💉: Innovating methods to enhance the efficacy and safety of pharmaceutical formulations.
  • Optimization of Pharmaceutical Formulations 💊: Improving drug stability, release profiles, and therapeutic outcomes.
  • Bioengineering Applications in Pharmaceutics 🌟: Integrating bioengineering techniques to address complex pharmaceutical challenges.
  • Interdisciplinary Research Initiatives 🔍: Collaborating across fields to advance research in Pharmaceutics and Bioengineering.
  • Innovative Drug-Device Combination Products 💡: Designing and evaluating novel drug delivery systems that combine pharmaceuticals with medical devices.
Publications top noted📜
  • Self-targeting fluorescent carbon dots for diagnosis of brain cancer cells
    📄 Authors: M Zheng, S Ruan, S Liu, T Sun, D Qu, H Zhao, Z Xie, H Gao, X Jing, Z Sun
    🏆 Journal: ACS Nano
    📅 Year: 2015
    🔍 Citations: 504
  • Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles
    📄 Authors: S Ruan, M Yuan, L Zhang, G Hu, J Chen, X Cun, Q Zhang, Y Yang, Q He, …
    🏆 Journal: Biomaterials
    📅 Year: 2015
    🔍 Citations: 365
  • Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release
    📄 Authors: S Ruan, X Cao, X Cun, G Hu, Y Zhou, Y Zhang, L Lu, Q He, H Gao
    🏆 Journal: Biomaterials
    📅 Year: 2015
    🔍 Citations: 280
  • Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
    📄 Authors: R Liu, C Luo, Z Pang, J Zhang, S Ruan, M Wu, L Wang, T Sun, N Li, L Han, …
    🏆 Journal: Chinese Chemical Letters
    📅 Year: 2023
    🔍 Citations: 271
  • Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy
    📄 Authors: C Hu, X Cun, S Ruan, R Liu, W Xiao, X Yang, Y Yang, C Yang, H Gao
    🏆 Journal: Biomaterials
    📅 Year: 2018
    🔍 Citations: 248
  • Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation
    📄 Authors: S Ruan, C Hu, X Tang, X Cun, W Xiao, K Shi, Q He, H Gao
    🏆 Journal: ACS Nano
    📅 Year: 2016
    🔍 Citations: 243
  • Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma
    📄 Authors: S Ruan, Q He, H Gao
    🏆 Journal: Nanoscale
    📅 Year: 2015
    🔍 Citations: 174
  • Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment
    📄 Authors: S Ruan, R Xie, L Qin, M Yu, W Xiao, C Hu, W Yu, Z Qian, L Ouyang, Q He, …
    🏆 Journal: Nano Letters
    📅 Year: 2019
    🔍 Citations: 151
  • A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration
    📄 Authors: X Cun, J Chen, S Ruan, L Zhang, J Wan, Q He, H Gao
    🏆 Journal: ACS Applied Materials & Interfaces
    📅 Year: 2015
    🔍 Citations: 136
  • Acid‐responsive transferrin dissociation and GLUT mediated exocytosis for increased blood–brain barrier transcytosis and programmed glioma targeting delivery
    📄 Authors: S Ruan, L Qin, W Xiao, C Hu, Y Zhou, R Wang, X Sun, W Yu, Q He, H Gao
    🏆 Journal: Advanced Functional Materials
    📅 Year: 2018
    🔍 Citations: 131
  • Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization
    📄 Authors: S Ruan, Y Zhou, X Jiang, H Gao
    🏆 Journal: Advanced Science
    📅 Year: 2021
    🔍 Citations: 120
  • A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan
    📄 Authors: X Cun, S Ruan, J Chen, L Zhang, J Li, Q He, H Gao
    🏆 Journal: Acta Biomaterialia
    📅 Year: 2016
    🔍 Citations: 118
  • A simple one-step method to prepare fluorescent carbon dots and their potential application in non-invasive glioma imaging
    📄 Authors: S Ruan, J Qian, S Shen, J Zhu, X Jiang, Q He, H Gao
    🏆 Journal: Nanoscale
    📅 Year: 2014
    🔍 Citations: 116

Ho Lini | Pharmacology | Best Researcher Award

Posted on by ScienceFather

🌟Prof Dr. Ho Lini, Pharmacology, Best Researcher Award🏆

Professor at National Chung Hsing University, Taiwan

Ho Lin (Jack, 林 赫) is an accomplished scientist and educator with expertise in cell biology, neurobiology, pharmacology, reproduction, endocrinology, and cancer biology. Currently serving as the Executive Director of the Science & Technology Division at the Taipei Economic & Cultural Office in Australia and a Distinguished Professor at the Department of Life Sciences, National Chung Hsing University (NCHU), Taiwan, Ho Lin has made significant contributions to the field of biomedical research through his academic pursuits, administrative roles, and collaborative projects. With a background in physiology from National Yang Ming University and biology from Tunghai University, Ho Lin has a strong foundation in both theoretical knowledge and practical research methodologies.

Author Metrics:

Ho Lin has a prolific publication record, with numerous articles published in prestigious scientific journals. As an established researcher, he has contributed to advancing scientific knowledge in various areas of biology and medicine. His publications have been cited extensively, reflecting the impact of his work within the scientific community. Additionally, Ho Lin’s expertise is recognized through his editorial roles in esteemed journals and his participation in scholarly activities such as peer review and guest editing.

Scopus Profile

ORCID Profile

Citations: 2,207 across 1,858 documents

h-index: 27

Number of Documents Authored: 85

Education:

Ho Lin earned his Doctor of Philosophy (Ph.D.) in Physiology from National Yang Ming University and his Bachelor of Science (B.S.) in Biology from Tunghai University. His academic journey provided him with a solid foundation in biomedical sciences, shaping his subsequent career in research and academia. Through rigorous training and interdisciplinary studies, Ho Lin developed expertise in multiple fields, enabling him to conduct innovative research and mentor aspiring scientists.

Research Focus:

Ho Lin’s research interests encompass hormone receptors in cancer biology, novel functions of hormone receptors, and neurobiology. His investigations aim to unravel the molecular mechanisms underlying disease pathogenesis and identify potential therapeutic targets. By elucidating the roles of hormone receptors in cancer progression and exploring their diverse functions in physiological processes, Ho Lin contributes to the development of novel treatment strategies and diagnostic tools.

Professional Journey:

Ho Lin’s professional journey spans various academic and administrative roles, reflecting his commitment to advancing scientific knowledge and fostering academic excellence. From his early career as a postdoctoral fellow at the National Health Research Institutes to his current positions as an Executive Director and Distinguished Professor, Ho Lin has demonstrated leadership, expertise, and dedication to his field. His contributions to education, research, and institutional governance have earned him recognition and respect within the scientific community.

Honors & Awards:

Throughout his career, Ho Lin has received numerous honors and awards in recognition of his outstanding contributions to science and academia. These accolades include the NCHU Distinguished Professorship, Distinguished Mentorship, and grants for distinguished young scholars. Ho Lin’s achievements reflect his excellence in research, teaching, and mentorship, inspiring future generations of scientists and contributing to the advancement of biomedical sciences.

Publications Noted & Contributions:

Ho Lin’s publications are noted for their significance in advancing scientific knowledge and addressing critical questions in biology and medicine. His research contributions span a wide range of topics, including hormone receptor signaling, cancer biology, neurobiology, and pharmacology. Through his publications, Ho Lin has disseminated novel findings, proposed innovative hypotheses, and contributed to the scientific discourse on various biological processes and disease mechanisms.

Metformin alters dendrite development and synaptic plasticity in rat cortical neurons

Published in Biochemical and Biophysical Research Communications, May 2024.

DOI: 10.1016/j.bbrc.2024.149874

Contributors: Muhammet Oner, Pang-Ting Cheng, Hsin-Yi Wang, Mei-Chih Chen, Ho Lin

Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1/STAT3/MYC pathways

Published in Toxicology in Vitro, December 2023.

DOI: 10.1016/j.tiv.2023.105768

Contributors: Chieh-Lin Jerry Teng, Pang-Ting Cheng, Yu-Chiao Cheng, Jia-Rung Tsai, Mei-Chih Chen, Ho Lin

RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells

Published in American Journal of Physiology-Cell Physiology, November 1, 2023.

DOI: 10.1152/ajpcell.00494.2022

Contributors: Wan-Ling Liao, Ho Lin, Yu-Hsuan Li, Tsung-Ying Yang, Mei-Chih Chen

Impacts of androgen pathway manipulation on patients with lung cancer

Published in Journal of Clinical Oncology, June 1, 2023.

DOI: 10.1200/jco.2023.41.16_suppl.e21010

Contributors: Po-Hsin Lee, Jeng-Sen Tseng, Yen-Hsiang Huang, Yu-Wei Hsu, Kuo-Hsuan Hsu, Tsung-Ying Yang, Ho Lin

Abstract A12: Androgen receptor inhibition is involved in Finasteride-reduced AML cell proliferation

Published in Blood Cancer Discovery, May 1, 2023.

DOI: 10.1158/2643-3249.aml23-a12

Contributors: Pang-Ting Cheng, Chieh-Lin Jerry Teng, Yu-Chiao Cheng, Mei-Chih Chen, Ho Lin

Research Timeline:

Ho Lin’s research timeline reflects a progressive trajectory characterized by continuous growth, innovation, and collaboration. From his early explorations as a graduate student to his current leadership roles, Ho Lin’s research journey has been marked by significant achievements, breakthroughs, and interdisciplinary collaborations. Through a combination of basic and translational research, Ho Lin has made notable contributions to understanding disease pathogenesis and developing therapeutic interventions.

Collaborations and Projects:

Ho Lin has actively engaged in collaborative projects with researchers and institutions worldwide, leveraging collective expertise and resources to address complex scientific challenges. His collaborations encompass multidisciplinary teams and interdisciplinary approaches, fostering innovation and knowledge exchange. By collaborating with diverse stakeholders, Ho Lin promotes synergistic research efforts and accelerates the translation of scientific discoveries into clinical applications.

Ke Yang | Pharmacology | Best Researcher Award

Posted on by ScienceFather

🌟Assoc Prof Dr. Ke Yang, Pharmacology, Best Researcher Award🏆

  •  Associate Professor at China Jiliang University, China

Yang Ke is a prominent figure in the field of Pharmacology of Traditional Chinese Medicine. With a background in Pharmacognosy and Molecular Biology and Biochemistry, Yang has made significant contributions to research and academia. Currently serving as an Associate Professor at China Jiliang University and as a Postdoctoral Researcher at the China Academy of Chinese Medical Sciences, Yang’s expertise lies in the study of medicinal plants and their therapeutic applications. With a focus on elucidating the molecular mechanisms underlying the pharmacological effects of natural compounds, Yang’s research has garnered recognition both nationally and internationally.

Author Metrics

Scopus Profile

Yang Ke’s scholarly impact is reflected in their author metrics, including citation counts, h-index, and publication metrics. Their publications have garnered attention from researchers worldwide, highlighting the significance of their contributions to the field.

Affiliation: China Jiliang University, Hangzhou, China

Scopus Author Identifier: Yang Ke’s publications are indexed in Scopus, a database of peer-reviewed literature, enabling tracking of citations and other metrics related to their scholarly work.

Citations: Yang Ke has received a total of 42 citations across 42 documents, indicating the impact of their research within the academic community.

Documents: Yang Ke has authored or co-authored 5 documents, which have contributed to their citation count.

h-index: The h-index is a metric used to measure both the productivity and impact of a researcher’s publications. With an h-index of 2, Yang Ke has published at least 2 papers that have each received at least 2 citations.

Education

Yang Ke pursued a Ph.D. in Pharmacognosy at Peking Union Medical College, where they investigated the therapeutic potential of natural products. Prior to this, Yang completed a Master’s degree in Molecular Biology and Biochemistry at China Jiliang University, laying the foundation for their interdisciplinary approach to research.

Research Focus

Yang Ke’s research primarily focuses on the pharmacology of traditional Chinese medicine, particularly the therapeutic properties of medicinal plants. Their work involves identifying bioactive compounds, elucidating their mechanisms of action, and exploring their potential applications in treating various diseases. Key areas of interest include diabetic peripheral neuropathy, atherosclerosis, and neurodegenerative disorders.

Professional Journey

Yang Ke’s professional journey encompasses roles as a Postdoctoral Researcher at the China Academy of Chinese Medical Sciences and an Associate Professor at China Jiliang University. Additionally, they have undertaken a secondment at the National Institute of Extremely-Weak Magnetic Field Infrastructure in Hangzhou. Through these positions, Yang has been instrumental in advancing research, mentoring students, and collaborating with esteemed colleagues in the field.

Honors & Awards

Throughout their career, Yang Ke has received recognition for their outstanding contributions to pharmacological research. Notable honors and awards include grants from national research and development plans, prestigious fellowships, and accolades for impactful publications.

Publications Noted & Contributions

Yang Ke has made significant contributions to the scientific community through their research publications. Notable works include studies on the therapeutic effects of natural compounds in diabetic neuropathy, atherosclerosis, and Alzheimer’s disease. Their research has been published in esteemed journals and has contributed to advancing knowledge in the field of pharmacology.

Structure of crude polysaccharides from Atractylodes lancea rhizome and treatment of diarrhea owing to spleen deficiency through intestinal flora

Authors: Wang, Y., Wang, S., Wang, T.-L., … Yang, K., Guo, L.-P.

Journal: Biomedical Chromatography, 2024

Citation Count: 0

A smartphone-integrated multi-model thermal immunochromatographic assay for sensitive detection of histamine in real samples

Authors: Zhang, B., Cai, D., Lang, Y., … Shentu, X., Yu, X.

Journal: Sensors and Actuators B: Chemical, 2023

Citation Count: 2

Research progress on effects of traditional Chinese medicine on myocardial ischemia–reperfusion injury: A review

Authors: Xing, N., Long, X.-T., Zhang, H.-J., … Yang, K., Lin, H.-B.

Journal: Frontiers in Pharmacology, 2022

Citation Count: 2

Overview of the preparation method, structure and function, and application of natural peptides and polypeptides

Authors: Feng, L., Wang, Y., Yang, J., … Lin, H.-B., Yang, K.

Journal: Biomedicine and Pharmacotherapy, 2022

Citation Count: 9

Progress in the treatment of diabetic peripheral neuropathy

Authors: Yang, K., Wang, Y., Li, Y.-W., … Zhou, P., Yu, X.-P.

Journal: Biomedicine and Pharmacotherapy, 2022

Citation Count: 32

Research Timeline

Yang Ke’s research timeline spans several years, encompassing their doctoral and postdoctoral studies, as well as their tenure as an Associate Professor. Over this period, they have undertaken various research projects, secured funding, and published numerous papers, contributing to the advancement of pharmacological research.

Collaborations and Projects

Yang Ke has engaged in collaborative research projects with colleagues both within their institution and internationally. These collaborations have led to interdisciplinary research endeavors, innovative discoveries, and the development of novel therapeutic approaches. Through active involvement in projects, Yang has fostered collaborations and contributed to the advancement of scientific knowledge in their field.

Hang Hu | Pharmacology | Best Researcher Award

Posted on by ScienceFather

🌟Dr. Hang Hu, Pharmacology, Best Researcher Award 🏆

  •   Doctorate at Changzhou University, China 

Hang Hu is a male teacher affiliated with Changzhou University’s School of Pharmacy. He specializes in anticancer drug delivery, particularly in the sub-division of nanomedicine for cancer photodynamic therapy. Hang holds a teacher qualification and has significant experience in academia, research, and publications.

Author Profile:

ORCID Profile

Education

Hang Hu completed his Bachelor’s degree in Applied Chemistry from Hubei University. He pursued further studies, obtaining a Master’s degree in Organic Chemistry and later a Doctorate in Biopharmaceutical Engineering from Huazhong University of Science and Technology.

Research Focus

Hang Hu’s research primarily revolves around cancer photodynamic therapy, with a focus on developing novel strategies to enhance its effectiveness. He works on overcoming limitations such as tumor hypoxia and insufficient photosensitizer uptake through the development of smart nanomedicines and innovative drug combinations.

Professional Journey

Hang Hu began his professional journey with research during his graduate studies, focusing on constructing anticancer drug delivery systems. After obtaining his doctoral degree, he joined Changzhou University as a teacher in 2018, where he continues his research in cancer photodynamic therapy.

Honors & Awards

Hang Hu has received recognition for his contributions to the field, including awards for his research and publications. His work has been acknowledged by reputable journals and academic institutions.

Publications & Contributions

Hang Hu has co-authored over 40 SCI papers and holds over 30 invention patents in the field of anticancer drug delivery and cancer photodynamic therapy. His research has been recognized by Materials Today Bio, Journal of Colloid and Interface Science, and ACS Applied Materials & Interfaces, among others.

Targeted Delivery of Doxorubicin to Hepatoma Cells by Lactobionic Acid-Decorated Dual Redox-Responsive Polyethylene Glycol-Doxorubicin Nanoparticles

  • Journal: International Journal of Nanoscience
  • Published: 2023-06
  • DOI: 10.1142/S0219581X23500199
  • Contributors: Yang Fu, Chaohui Ji, Zhiheng Ma, Defeng Xu, Hang Hu
  • Summary: This study focuses on enhancing the delivery of doxorubicin to hepatoma cells using nanoparticles decorated with lactobionic acid. The nanoparticles are designed to respond to redox conditions, providing targeted and responsive drug delivery.

Reduction-responsive worm-like nanoparticles for synergistic cancer chemo-photodynamic therapy

  • Journal: Materials Today Bio
  • Published: 2023-02
  • DOI: 10.1016/j.mtbio.2023.100542
  • Contributors: Hang Hu, Defeng Xu, Qingbo Xu, Yuxiang Tang, Jun Hong, Yu Hu, Jianhao Wang, Xinye Ni
  • Summary: This research introduces reduction-responsive nanoparticles for combined chemo-photodynamic therapy in cancer treatment. These nanoparticles offer a synergistic effect by combining chemotherapy and photodynamic therapy to enhance therapeutic outcomes.

Conjugates of lactobionic acid and IR820: New photosensitizers for efficient photodynamic therapy of hepatoma cells

  • Journal: Drug Development Research
  • Published: 2022-12
  • DOI: 10.1002/ddr.22007
  • Contributors: Xiaoyin Yuan, Yayu Tao, Wen Xiao, Kunda Du, Hang Hu, Defeng Xu, Qingbo Xu
  • Summary: This study presents new photosensitizers composed of lactobionic acid and IR820 for efficient photodynamic therapy targeting hepatoma cells. These conjugates aim to improve the effectiveness of photodynamic therapy in treating liver cancer.

Mesoporous polydopamine-based multifunctional nanoparticles for enhanced cancer phototherapy

  • Journal: Journal of Colloid and Interface Science
  • Published: 2022-04
  • DOI: 10.1016/j.jcis.2021.12.172
  • Contributors: Hang Hu
  • Summary: The research introduces multifunctional nanoparticles based on mesoporous polydopamine for enhanced cancer phototherapy. These nanoparticles likely offer multiple functionalities to improve the efficacy of phototherapy in cancer treatment.

Polyethylene glycol-modified mesoporous polydopamine nanoparticles co-loaded with dimethylcurcumin and indocyanine green for combination therapy of castration-resistant prostate cancer

  • Journal: Journal of Drug Delivery Science and Technology
  • Published: 2022-03
  • DOI: 10.1016/j.jddst.2022.103158
  • Contributors: Jun Hong, Yating Tang, Mengting Zhou, Jing Deng, Hang Hu, Defeng Xu
  • Summary: This study presents nanoparticles co-loaded with dimethylcurcumin and indocyanine green, modified with polyethylene glycol, for combination therapy targeting castration-resistant prostate cancer. The combination therapy approach aims to improve treatment outcomes for this type of cancer.

Author Metrics

Hang Hu’s research output reflects his significant contributions to the field. With an H-index of 15 and numerous publications in high-impact journals, he has established himself as a prominent researcher in cancer photodynamic therapy.

Research Timeline

Hang Hu’s research journey began during his graduate studies, where he started working on constructing anticancer drug delivery systems. Since joining Changzhou University in 2018, he has continued to advance his research in cancer photodynamic therapy, focusing on developing innovative strategies to overcome its limitations.

 

Sukesh Gupta | Pharmacology | Best Researcher Award

Posted on by ScienceFather

🌟Dr. Sukesh Gupta, Pharmacology, Best Researcher Award🏆

Doctorate at School of Medicine Wayne State University, DETROIT MI USA, United States

Dr. Sukesh Kumar Gupta is a highly skilled Postdoctoral Scholar specializing in Pharmacology, with a keen focus on neurobiology and drug discovery. His academic journey began with a Bachelor’s degree in Pharmacy from Integral University, Lucknow, India, followed by a Master’s and a Doctorate in Pharmacology from Central University (BBAU), Lucknow, and Indian Institute of Technology (BHU), Varanasi, respectively. Currently, Dr. Gupta is engaged in postdoctoral research at Wayne State University in Detroit, MI, USA.

Author Metrics:

Google Scholar Profile

Orcid Profile

Scopus Profile

Dr. Gupta’s contributions to scientific literature are characterized by high-quality research output, as evidenced by his authorship of multiple peer-reviewed articles and conference presentations. His work demonstrates a commitment to rigorous methodology, innovative experimentation, and impactful scientific discovery.

  • Dr. Sukesh Kumar Gupta has a total of 285 citations and an h-index of 10.
  • His i10-index, which represents the number of publications with at least 10 citations each, is 10.

These metrics indicate the impact and influence of Dr. Gupta’s research within the scientific community. The h-index of 10 suggests that he has published 10 papers that have each been cited at least 10 times, demonstrating a significant level of recognition and impact in his field. Additionally, the i10-index of 10 highlights the consistency of his contributions, with a substantial number of his publications receiving a notable level of citation. Overall, these metrics reflect Dr. Gupta’s scholarly impact and the relevance of his research within the field of pharmacology.

Education:

Dr. Gupta holds a Ph.D. in Pharmacology, showcasing his dedication to advancing knowledge in the field. His academic journey also includes a Master’s degree in Pharmacology and a Bachelor’s degree in Pharmacy, providing him with a strong foundation in pharmaceutical sciences.

Research Focus:

Dr. Gupta’s research primarily centers on neurobiology and drug discovery, particularly focusing on areas such as neuronal regeneration, Alzheimer’s disease, autoimmune uveitis, and the effects of electromagnetic radiation on cognitive function and behavior in animal models. His expertise lies in various experimental techniques ranging from cell culture and molecular biology to animal behavioral studies and drug development.

Professional Journey:

Having served as an Assistant Professor of Pharmacology at prestigious institutions in India, Dr. Gupta transitioned to postdoctoral research positions in the United States. His professional journey reflects his commitment to academic excellence and research innovation, spanning both teaching and cutting-edge scientific inquiry.

Honors & Awards:

Throughout his academic and professional career, Dr. Gupta has been honored with prestigious awards and fellowships, including the GPAT Fellowship and Teaching Assistant fellowship. These accolades underscore his exceptional contributions to the field of pharmacology and his dedication to advancing scientific knowledge.

Publications Top Noted & Contributions:

Dr. Gupta has made significant contributions to scientific literature, with numerous peer-reviewed publications in reputable journals. His research findings encompass a wide range of topics, including the development of novel drug therapies, elucidation of molecular mechanisms underlying neurodegenerative diseases, and exploration of potential therapeutic targets for various conditions.

Title: “Electromagnetic radiation 2450 MHz exposure causes cognition deficit with mitochondrial dysfunction and activation of intrinsic pathway of apoptosis in rats”

  • Authors: SK Gupta, MK Mesharam, S Krishnamurthy
  • Journal: Journal of Biosciences
  • Volume: 43
  • Pages: 263-276
  • Year: 2018

Title: “Biological profiling of piperazinediones for the management of anxiety”

  • Authors: D Kumar, SK Gupta, A Ganeshpurkar, R Singh, D Kumar, N Das, …
  • Journal: Pharmacology Biochemistry and Behavior
  • Volume: 176
  • Pages: 63-71
  • Year: 2019

Title: “Efficacy of variable dosage of aspirin in combating methotrexate-induced intestinal toxicity”

  • Authors: SK Gupta, S Gautam, JK Rawat, M Singh, SA Saraf, G Kaithwas
  • Journal: RSC Advances
  • Volume: 5
  • Issue: 13
  • Pages: 9354-9360
  • Year: 2015

Title: “Neuroprotective effects of quercetin produced by an endophytic fungus Nigrospora oryzae isolated from Tinospora cordifolia”

  • Authors: R Vig, F Bhadra, SK Gupta, K Sairam, M Vasundhara
  • Journal: Journal of Applied Microbiology
  • Volume: 132
  • Issue: 1
  • Pages: 365-380
  • Year: 2022

Title: “Evaluation of some pathophysiological and pharmacological effects in rats exposed to electromagnetic radiation”

  • Author: SK Gupta
  • Affiliation: IIT BHU Varanasi

Research Timeline:

Dr. Gupta’s research journey has evolved over the years, from his early academic pursuits in pharmacology to his current endeavors as a postdoctoral scholar. His timeline reflects a progression of research interests and expertise, with each phase contributing to his overarching goal of advancing knowledge and improving human health through pharmaceutical innovation and neurobiological research.